DJ Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC 30-Aug-2023 / 13:19 GMT/BST=----------------------------------------------------------------------------------------------------------------------
The Vanguard Group, Inc. Form 8.3 30-Aug-2023 / 13:19 GMT/BST =---------------------------------------------------------------------------------------------------------------------- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code 1. KEY INFORMATION Full name of discloser: The Vanguard Group, Inc.
Details of any open stock-settled derivative positions , or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 .Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE
Class of relevant Product description Exercising/ exercised security against Number of securities Exercise price per unit e.g. call option Other dealings Is a Supplemental Form 8 attached? No Date of disclosure: 30 August 2023 Contact name: Shawn Acker Telephone number*: 001-610-669-6713 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
- The Vanguard Group, Inc.: Horizon Therapeutics PlcDJ Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc The Vanguard Group, Inc. ( irsh) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc 28-Aug-2023 / 15:33 GMT/BST=----------------------------------------------------------------------------------------------------------------------
Lire la suite »
- The Vanguard Group, Inc.: Dechra Pharmaceuticals PLCDJ Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC 28-Aug-2023 / 15:31 GMT/BST=----------------------------------------------------------------------------------------------------------------------
Lire la suite »
- The Vanguard Group, Inc.: Horizon Therapeutics PlcDJ Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc The Vanguard Group, Inc. ( irh) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc 30-Aug-2023 / 13:18 GMT/BST=----------------------------------------------------------------------------------------------------------------------
Lire la suite »
DeFi Technologies Inc.-Tochter Valour Inc. bringt 3 neue Produkte auf NGM auf den MarktZug, Schweiz, und Toronto, Kanada (ots/PRNewswire) - - Valour Inc., das Tochterunternehmen von DeFi Technologies, führt drei auf EUR lautende Produkte auf NGM ein: Valour Ethereum Zero EUR, Valour Solana
Lire la suite »
Vonovia SE (ex Deutsche Annington) Conviction Buy List (Goldman Sachs Group Inc.) 29.08.2023 | AnalyseVonovia SE (ex Deutsche Annington) Conviction Buy List (Goldman Sachs Group Inc.) 29.08.2023 | Analyse | finanzen.net
Lire la suite »